Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SMS PHARMA Plunges 6%; BSE HEALTHCARE Index Up 0.9%
Tue, 6 Aug 10:45

SMS PHARMA Plunges 6%; BSE HEALTHCARE Index Up 0.9%Image source: phive2015/www.istockphoto.com

SMS PHARMA share price has plunged 6% and is presently trading at Rs 294.3.

Meanwhile, the BSE HEALTHCARE index is at 40,425.9 (up 0.9%).

Among the top losers in the BSE HEALTHCARE index today are FORTIS HEALTHCARE (down 0.9%) and Lupin (down 0.8%).

GLAND PHARMA (up 3.8%) and ASTRAZENECA PHARMA (up 3.8%) are among the top gainers today.

Over the last one year, SMS PHARMA has moved up from Rs 115.4 to Rs 294.3, registering a gain of Rs 178.9 (up 155.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,485.7 to 40,425.9, registering a gain of 47.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 127.3%), GRANULES INDIA (up 102.8%) and SUVEN PHARMACEUTICALS (up 102.1%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,153.9 (up 0.5%).

The top gainers among the BSE Sensex today are Tech Mahindra (up 2.2%) and JSW Steel (up 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,155.9 (up 0.4%). Tech Mahindra and Grasim Industries are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,782.8 to 79,153.9, registering a gain of 13,371.1 points (up 20.3%).

SMS PHARMA Financial Update...

SMS PHARMA net profit grew 85.9% YoY to Rs 164 million for the quarter ended June 2024, compared to a profit of Rs 88 million a year ago. Net sales rose 21.5% to Rs 1,645 million during the period as against Rs 1,353 million in April-June 2023.

For the year ended March 2023, SMS PHARMA reported 94.3% decrease in net profit to Rs 39 million compared to net profit of Rs 679 million during FY22. Revenue of the company grew 1.2% to Rs 4,914 million during FY23.

The current Price to earnings ratio of SMS PHARMA, based on rolling 12 month earnings, stands at 43.9.


Equitymaster requests your view! Post a comment on "SMS PHARMA Plunges 6%; BSE HEALTHCARE Index Up 0.9%". Click here!